Generic placeholder image

Cardiovascular & Hematological Disorders-Drug Targets

Editor-in-Chief

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Letter to the Editor

Cardiovascular Considerations of Remdesivir and Favipiravir in the Treatment of COVID-19

Author(s): Mohammad Amin Shahrbaf, Mohammadreza Tabary and Isa Khaheshi*

Volume 21 , Issue 2 , 2021

Published on: 11 August, 2021

Page: [88 - 90] Pages: 3

DOI: 10.2174/1871529X21666210812103535

Abstract

After the outbreak of COVID-19, many novel drugs have been introduced to improve patients’ conditions. Remdesivir and Favipiravir are among the most common drugs used against SARS-CoV-2. Although promising, cardiovascular side effects of these drugs should be considered by physicians and nurses. In this study, we searched databases for assessing the cardiovascular side effects of Remdesivir and Favipiravir. It seems that despite the beneficial effects of these drugs, due to the cardiovascular complications of COVID-19 and cardiovascular side effects of these drugs, which can overlap with each other, the use of these drugs can be a challenging issue in the cardiovascular practice.

Keywords: Remdesivir, favipiravir, COVID-19, heart, cardiovascular, side effect.


© 2022 Bentham Science Publishers | Privacy Policy